HM-3-HSA exhibits potent anti-angiogenesis and antitumor activity in hepatocellular carcinoma.
Li T, Ge G, Zhang H, Wang R, Liu Y, Zhang Q, Yue Z, Ma W, Li W, Zhang J, Yang H, Wang P, Zhao J, Fang Y, Xie Q, Wang M, Li Y, Zhu H, Li H.
Li T, et al.
Eur J Pharm Sci. 2021 Dec 1;167:106017. doi: 10.1016/j.ejps.2021.106017. Epub 2021 Sep 21.
Eur J Pharm Sci. 2021.
PMID: 34555448